A Next Generation Synthesis of BACE1 Inhibitor Verubecestat (MK-8931)
2018
The development of a commercial manufacturing route to verubecestat (MK-8931) is described, highlights of which include the application of a continuous processing step to outcompete fast proton transfer in a Mannich-type ketimine addition, a copper-catalyzed amidation reaction, and an optimized guanidinylation procedure to form the key iminothiadiazine dioxide core.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
16
Citations
NaN
KQI